Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × HIV Infections × Standard of Care × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Pancreatic Neoplasms 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Leukemia 4 Recurrence 3 Neoplasms, Plasma Cell 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Radiodermatitis 2 Neoplasms by Site 2 Myelodysplastic Syndromes 2 Melanoma 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Transitional Cell 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Etoposide 3 Cyclophosphamide 3 Biopsy 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Watchful Waiting 2 Vincristine 2 Specimen Handling 2 Rituximab 2 Prednisone 2 Polymerase Chain Reaction 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Light Coagulation 2 Imiquimod 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Gene Expression Profiling 2 Fluorouracil 2 Doxorubicin 2 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 prednylidene 1 pembrolizumab 1 fludarabine 1 emvododstat 1 efineptakin alfa 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 cabozantinib 1 Vorinostat 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡